Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agustina Gugliotta

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Biotechnology|July 24, 2019
Effect of ANITVNITV peptide fusion on the bioactivity and pharmacokinetics of human IFN-α2b and a hyper-N-glycosylated variantAgustina Gugliotta, Natalia Ceaglio, Ricardo Kratje, et al.
Transcription|June 25, 2026
Endogenous eukaryotic CHO-K1 cell promoters as tools to improve the production of a difficult-to-express recombinant proteinMaría Belén Ardusso, Agustina Gugliotta, Victoria Gastaldi, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 19, 2017
Strategies to Develop Therapeutic N- and O-Hyperglycosylated ProteinsAgustina Gugliotta, Natalia Ceaglio, Marina Etcheverrigaray, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|August 30, 2016
Epigenetic modulations rendering cell-to-cell variability and phenotypic metastabilityShawal Spencer, Agustina Gugliotta, Natascha Gödecke, et al.
Journal of Biotechnology|December 24, 2014
Stability of single copy transgene expression in CHOK1 cells is affected by histone modifications but not by DNA methylationShawal Spencer, Agustina Gugliotta, Jennifer Koenitzer, et al.
Plasmid|February 8, 2022
Screening of CHO-K1 endogenous promoters for expressing recombinant proteins in mammalian cell culturesIleana Tossolini, Agustina Gugliotta, Fernando López Díaz, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 22, 2016
Glycosylation and antiproliferative activity of hyperglycosylated IFN-α2 potentiate HEK293 cells as biofactoriesAgustina Gugliotta, Natalia Ceaglio, Brenda Raud, et al.
Journal of Biotechnology|January 26, 2016
Improvement of in vitro stability and pharmacokinetics of hIFN-α by fusing the carboxyl-terminal peptide of hCG β-subunitNatalia Ceaglio, Agustina Gugliotta, María Belén Tardivo, et al.
Pharmaceutical Research|January 14, 2021
Pharmacokinetics Versus In Vitro Antiproliferative Potency to Design a Novel Hyperglycosylated hIFN-α2 BiobetterAgustina Gugliotta, María Jesús Leopold, Eduardo Mufarrege, et al.
Applied Microbiology and Biotechnology|November 4, 2022
Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 proteinMaría Celeste Rodríguez, Natalia Ceaglio, Agustina Gugliotta, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Biotechnology|July 24, 2019
Effect of ANITVNITV peptide fusion on the bioactivity and pharmacokinetics of human IFN-α2b and a hyper-N-glycosylated variantAgustina Gugliotta, Natalia Ceaglio, Ricardo Kratje, et al.
Transcription|June 25, 2026
Endogenous eukaryotic CHO-K1 cell promoters as tools to improve the production of a difficult-to-express recombinant proteinMaría Belén Ardusso, Agustina Gugliotta, Victoria Gastaldi, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 19, 2017
Strategies to Develop Therapeutic N- and O-Hyperglycosylated ProteinsAgustina Gugliotta, Natalia Ceaglio, Marina Etcheverrigaray, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|August 30, 2016
Epigenetic modulations rendering cell-to-cell variability and phenotypic metastabilityShawal Spencer, Agustina Gugliotta, Natascha Gödecke, et al.
Journal of Biotechnology|December 24, 2014
Stability of single copy transgene expression in CHOK1 cells is affected by histone modifications but not by DNA methylationShawal Spencer, Agustina Gugliotta, Jennifer Koenitzer, et al.
Plasmid|February 8, 2022
Screening of CHO-K1 endogenous promoters for expressing recombinant proteins in mammalian cell culturesIleana Tossolini, Agustina Gugliotta, Fernando López Díaz, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 22, 2016
Glycosylation and antiproliferative activity of hyperglycosylated IFN-α2 potentiate HEK293 cells as biofactoriesAgustina Gugliotta, Natalia Ceaglio, Brenda Raud, et al.
Journal of Biotechnology|January 26, 2016
Improvement of in vitro stability and pharmacokinetics of hIFN-α by fusing the carboxyl-terminal peptide of hCG β-subunitNatalia Ceaglio, Agustina Gugliotta, María Belén Tardivo, et al.
Pharmaceutical Research|January 14, 2021
Pharmacokinetics Versus In Vitro Antiproliferative Potency to Design a Novel Hyperglycosylated hIFN-α2 BiobetterAgustina Gugliotta, María Jesús Leopold, Eduardo Mufarrege, et al.
Applied Microbiology and Biotechnology|November 4, 2022
Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 proteinMaría Celeste Rodríguez, Natalia Ceaglio, Agustina Gugliotta, et al.
Pageof 2